STD & HIV/ AIDS and Emerging Viral Diseases

The human immunodeficiency virus is a lentivirus that causes HIV infection and AIDS. HIV diagnosis is done by testing your blood or saliva for antibodies to the virus. HIV/AIDS clinical trials are research studies done to have a better approach, distinguish, or treat HIV/AIDS. Clinical trials are the predominant way to determine if new medical approaches to HIV/AIDS are safe and effective in people.Examples of recent emerging viral diseases include Zika virus, Ebola virus, and SARS-CoV-2 (the virus responsible for COVID-19). These viruses often emerge in regions with high population densities, poor healthcare infrastructure, and close human-animal interactions, creating conditions for viruses to jump from animals to humans (zoonotic spillover). The global spread of COVID-19 demonstrated how rapidly emerging viral diseases can lead to pandemics, causing widespread illness, death, and social disruption. The response to emerging viral diseases requires rapid surveillance, research, and public health interventions, including the development of vaccines and antiviral treatments. For example, the rapid development and deployment of mRNA vaccines for COVID-19 were a significant milestone in responding to an emerging viral disease. Ongoing research into antiviral drugs, improved diagnostics, and better understanding of viral transmission dynamics are essential for managing the impact of new viruses and preventing future outbreaks.

    STD & HIV/ AIDS and Emerging Viral Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in